&#226;€‹Biopharmaceutical company.
Issues related to the FDA and the STATES Act (S. 3032), HHS pertaining to CBD policy. Appropriations issues related to the FDA CBD products, HHS pertaining to CBD policy. Issues related to the FDA STATES Act (S. 3032), and Health and Human Services pertaining to CBD policies.
MED - Medical/Disease Research/Clinical Labs BUD - Budget/Appropriations HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN